A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma
Abstract Background Lung adenocarcinoma (LUAD) is the most common malignant tumor that seriously affects human health. Previous studies have indicated that abnormal levels of glycosylation promote progression and poor prognosis of lung cancer. Thus, the present study aimed to explore the prognostic...
Main Authors: | Jin-xiao Liang, Qian Chen, Wei Gao, Da Chen, Xin-yu Qian, Jin-qiao Bi, Xing-chen Lin, Bing-bing Han, Jin-shi Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | BMC Bioinformatics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12859-022-05109-8 |
Similar Items
-
Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
by: Linbin Hua, et al.
Published: (2023-05-01) -
Integrated analysis of purine metabolism assists in predicting prognosis and treatment decisions for patients with lung adenocarcinoma
by: Tingting Zhang, et al.
Published: (2024-04-01) -
Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
by: Xiaoqing Ma, et al.
Published: (2023-11-01) -
A novel necroptosis signature for predicting survival in lung adenocarcinoma
by: Kui Zang, et al.
Published: (2023-11-01) -
The screening of immune-related biomarkers for prognosis of lung adenocarcinoma
by: Zhonghui Liu, et al.
Published: (2021-01-01)